☆ 3.8 Article

#AMRrounds: a systematic educational approach for navigating bench to bedside antimicrobial resistance

JAC-ANTIMICROBIAL RESISTANCE (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Pharmacology & Pharmacy

A Retrospective Case Series of Concomitant Carbapenem and Valproic Acid Use: Are Best Practice Advisories Working?

Andrew J. Fratoni et al.

Summary: This study assessed the efficacy of a Best Practice Advisory (BPA) in avoiding simultaneous use of carbapenems and valproic acid (VPA), and provided information on the use of these drugs, clinical implications, and potential alternative treatments. The study found that co-prescribing of carbapenems and VPA was rare, but the BPA was ineffective in 63% of cases.

JOURNAL OF PHARMACY PRACTICE (2023)

添加到收藏夹

Article Infectious Diseases

Effect of restricting piperacillin/tazobactam prescription on rates of antimicrobial resistance in gram-negative bacteria and antibiotic consumption

Jihyu Oh et al.

Summary: This study investigated the changes in antibiotic consumption and antimicrobial resistance rates after restricting piperacillin/tazobactam. The results showed a significant decrease in the consumption of piperacillin/tazobactam after implementing the restriction policy. Additionally, the resistance rates of Acinetobacter spp. and other bacteria decreased significantly, indicating a positive impact of piperacillin/tazobactam restriction on controlling bacterial resistance.

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2023)

添加到收藏夹

Review Microbiology

Molecular mechanisms of antibiotic resistance revisited

Elizabeth M. Darby et al.

Summary: Antibiotic resistance is a global health emergency, and understanding the molecular mechanisms that bacteria use to resist antimicrobials is critical. Recent advances in research can aid in developing new antimicrobial therapies.

NATURE REVIEWS MICROBIOLOGY (2023)

添加到收藏夹

Article Environmental Sciences

Implementation of A Year-Long Antimicrobial Stewardship Program in A 227-Bed Community Hospital in Southern Italy

Giuseppe Davide Albano et al.

Summary: This article describes the implementation of an Antimicrobial Stewardship (AMS) program in a hospital, which achieved multiple improvements in clinical, microbiological, and economic outcome measures by optimizing antibiotic use, limiting the spread of multidrug-resistant organisms (MDRO), improving therapeutic efficacy and clinical outcomes, and reducing costs.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2023)

添加到收藏夹

Article Critical Care Medicine

Epidemiology and outcomes of hospital-acquired bloodstream infections in intensive care unit patients: the EUROBACT-2 international cohort study

Alexis Tabah et al.

Summary: This study investigated hospital-acquired bloodstream infections (HA-BSI) in 2600 adult patients from 333 ICUs in 52 countries. HA-BSI were frequently caused by Gram-negative, carbapenem-resistant, and difficult-to-treat pathogens. Antimicrobial resistance led to delays in adequate antimicrobial therapy, resulting in high mortality rates.

INTENSIVE CARE MEDICINE (2023)

添加到收藏夹

Article Infectious Diseases

In vitro activity of aztreonam in combination with newly developed β-lactamase inhibitors against MDR Enterobacterales and Pseudomonas aeruginosa producing metallo-β-lactamases

Christophe Le Terrier et al.

Summary: The in vitro activity of aztreonam in combination with novel beta-lactamase inhibitors was evaluated against MDR MBL-producing Enterobacterales and Pseudomonas aeruginosa clinical isolates. The results showed that combinations including aztreonam and the inhibitors had significant activity against the isolates.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2023)

添加到收藏夹

Review Medicine, General & Internal

Association Between Antimicrobial Stewardship Programs and Antibiotic Use Globally: A Systematic Review and Meta-Analysis

Kyaw Zay Ya et al.

Summary: This study synthesized current evidence on the association between antimicrobial stewardship programs (ASPs) and antibiotic consumption globally. It found that ASPs were effective in reducing antibiotic consumption in healthcare settings and low- and middle-income countries.

JAMA NETWORK OPEN (2023)

添加到收藏夹

Article Infectious Diseases

Global epidemiology and clinical outcomes of carbapenem-resistant Pseudomonas aeruginosa and associated carbapenemases (POP): a prospective cohort study

Jinnethe Reyes et al.

Summary: This study investigated the characteristics and outcomes of carbapenem-resistant Pseudomonas aeruginosa (CRPA) infections and the distribution and clinical significance of carbapenemases. The results showed that carbapenemase-producing CRPA infections were associated with increased 30-day mortality, and the prevalence of carbapenemase genes varied by region. These findings highlight the therapeutic challenges posed by these carbapenem-resistant organisms.

LANCET MICROBE (2023)

添加到收藏夹

Review Infectious Diseases

Tigecycline antibacterial activity, clinical effectiveness, and mechanisms and epidemiology of resistance: narrative review

Sajad Yaghoubi et al.

Summary: Tigecycline is a unique semisynthetic antimicrobial agent developed to treat polymicrobial infections caused by multidrug-resistant pathogens. By adding a glycyclamide moiety to the structure of minocycline, tigecycline is able to bypass tetracycline resistance mechanisms. It is currently approved for complicated skin infections, intra-abdominal infections, and community-acquired bacterial pneumonia in adults.

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2022)

添加到收藏夹

Article Immunology

Infectious Diseases Society of America Guidance on the Treatment of AmpC β-Lactamase-Producing Enterobacterales, Carbapenem-Resistant Acinetobacter baumannii, and Stenotrophomonas maltophilia Infections

Pranita D. Tamma et al.

Summary: The Infectious Diseases Society of America (IDSA) has provided updated guidance on the treatment of antimicrobial-resistant infections, focusing on treating AmpC-producing Enterobacterales, carbapenem-resistant Acinetobacter baumannii, and Stenotrophomonas maltophilia infections. The guidance is based on clinical experience, expert opinion, and a review of available literature, as published data on optimal treatment options are limited. This document emphasizes treatment approaches for infections in the United States, considering differences in resistance epidemiology and the availability of specific anti-infectives internationally.

CLINICAL INFECTIOUS DISEASES (2022)

添加到收藏夹

Article Immunology

Cefiderocol for the Treatment of Infections Due to Metallo-B-lactamase-Producing Pathogens in the CREDIBLE-CR and APEKS-NP Phase 3 Randomized Studies

Jean-Francois Timsit et al.

Summary: The CREDIBLE-CR and APEKS-NP studies showed that cefiderocol treatment is effective against gram-negative bacteria producing metallo-B-lactamases, with favorable rates of clinical cure, microbiological eradication, and all-cause mortality compared to other treatment options.

CLINICAL INFECTIOUS DISEASES (2022)

添加到收藏夹

Article Infectious Diseases

European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine)

Mical Paul et al.

Summary: These guidelines address the targeted antibiotic treatment of 3GCephRE and carbapenem-resistant Gram-negative bacteria, focusing on the effectiveness of individual antibiotics and on combination versus monotherapy. Most recommendations are based on low-certainty evidence.

CLINICAL MICROBIOLOGY AND INFECTION (2022)

添加到收藏夹

Article Infectious Diseases

Antimicrobial activities of aztreonam-avibactam and comparator agents tested against Enterobacterales from European hospitals analysed by geographic region and infection type (2019-2020)

Helio S. Sader et al.

Summary: The study evaluated the activity of aztreonam-avibactam against Enterobacterales isolates from European medical centers and the occurrence of carbapenemases. The results showed that aztreonam-avibactam had high inhibitory activity against Enterobacterales isolates and retained potent activity against resistant strains. The study also found that isolates from the Eastern European and Mediterranean region had lower susceptibility to comparator agents compared to isolates from Western Europe.

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2022)

添加到收藏夹

Article Infectious Diseases

Impact of ceftazidime/avibactam versus best available therapy on mortality from infections caused by carbapenemase-producing Enterobacterales (CAVICOR study)

Juan Jose Caston et al.

Summary: The study found that ceftazidime/avibactam is an effective alternative for the treatment of carbapenemase-producing Enterobacterales (CPE) infections, especially in patients with certain high scores. Multivariate analysis showed that treatment with ceftazidime/avibactam was associated with survival, while high INCREMENT-CPE scores and SOFA scores were associated with higher mortality.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2022)

添加到收藏夹

Article Medicine, General & Internal

Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis

Christopher J. L. Murray et al.

Summary: Antimicrobial resistance (AMR) poses a significant threat to global human health, and this study provides the most comprehensive estimates of AMR burden to date. By estimating deaths and disability-adjusted life-years (DALYs) associated with bacterial AMR in 204 countries and territories in 2019, the study highlights the impact of resistance and the leading pathogen-drug combinations contributing to it.

LANCET (2022)

添加到收藏夹

Article Microbiology

Structural Characterization of the D179N and D179Y Variants of KPC-2 β-Lactamase: Ω-Loop Destabilization as a Mechanism of Resistance to Ceftazidime-Avibactam

T. A. Alsenani et al.

Summary: The structural study of KPC-2 D179 variants revealed destabilization of the Omega loop, contributing to ceftazidime-avibactam resistance.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2022)

添加到收藏夹

Article Immunology

Infectious Diseases Society of America 2022 Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P. aeruginosa)

Pranita D. Tamma et al.

Summary: This article provides updated guidance on the treatment of infections caused by ESBL-E, CRE, and DTR-P. aeruginosa. The guidance was developed by a panel of infectious diseases specialists and includes preferred and alternative treatment recommendations. The document emphasizes the importance of consulting with an infectious diseases specialist for the treatment of antimicrobial-resistant infections.

CLINICAL INFECTIOUS DISEASES (2022)

添加到收藏夹

Article Infectious Diseases

Ceftolozane/tazobactam for hospital-acquired/ventilator-associated bacterial pneumonia due to ESBL-producing Enterobacterales: a subgroup analysis of the ASPECT-NP clinical trial

David L. Paterson et al.

Summary: This study confirms the efficacy of ceftolozane/tazobactam in treating HABP/VABP involving ESBL-positive and/or AmpC-producing pathogens.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2022)

添加到收藏夹

Review Oncology

Conceptual framework of antibiotic stewardship programs in reducing ESBL-producing Enterobacteriaceae: a systematic review and meta-analysis

Masoud Keikha et al.

Summary: Antimicrobial stewardship programs (ASPs) are considered an important strategy in optimizing antibiotic consumption and reducing the emergence of drug-resistant microorganisms. A study found that implementing ASPs reduced the prevalence of ESBL-producing Enterobacteriaceae infections by 11.8%. Overall, ASPs were found to be effective in reducing these infections.

JOURNAL OF CHEMOTHERAPY (2022)

添加到收藏夹

Article Infectious Diseases

Epidemiology and In Vitro Activity of Ceftazidime/Avibactam, Meropenem/Vaborbactam and Imipenem/Relebactam against KPC-Producing K. pneumoniae Collected from Bacteremic Patients, 2018 to 2020

Federica Bovo et al.

Summary: This study assessed the resistance to novel beta-lactamase inhibitor combinations in KPC-producing K. pneumoniae strains isolated from patients with bloodstream infections. The results showed varying resistance rates to different beta-lactamase inhibitor combinations, with IMI-REL being the most effective. Genotypic analysis revealed mutations in the bla(KPC-3) gene in KPC-Kp strains resistant to CAZ-AVI, while strains resistant to CAZ-AVI, MER-VAB, and/or IMI-REL all carried the bla(KPC-3) gene.

ANTIBIOTICS-BASEL (2022)

添加到收藏夹

Review Microbiology

Klebsiella pneumoniae Carbapenemase Variants Resistant to Ceftazidime-Avibactam: an Evolutionary Overview

Claire Amaris Hobson et al.

Summary: This review describes the mutational landscape of KPC beta-lactamase towards ceftazidime-avibactam resistance, showing that resistance is associated with three hot spots and a high representation of insertions and deletions compared to other beta-lactamases. The extension of resistance to ceftazidime-avibactam is accompanied by a trade-off in resistance to other beta-lactams and a decrease in enzyme stability. The natural stability of KPC could explain its propensity to acquire in vivo mutations conferring resistance to ceftazidime-avibactam.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2022)

添加到收藏夹

Article Infectious Diseases

Susceptibility of OXA-48-producing Enterobacterales to imipenem/relebactam, meropenem/vaborbactam and ceftazidime/avibactam

Remy A. Bonnin et al.

Summary: This study demonstrates that the addition of relebactam and vaborbactam did not significantly modify the susceptibility of OXA-48-like-producing Enterobacterales to imipenem and meropenem. However, the addition of avibactam strongly restored ceftazidime susceptibility.

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2022)

添加到收藏夹

Article Infectious Diseases

Impact of antimicrobial stewardship on antibiogram, consumption and incidence of multi drug resistance

Rula M. Darwish et al.

Summary: The study evaluates the impact of antimicrobial stewardship programs in two hospitals with different approaches. The results show improvements in bacterial susceptibility to antibiotics and reductions in the incidence of multidrug resistance. However, there is a need to enhance the program by recruiting additional staff, implementing educational programs, and monitoring outcomes for greater efficiency, cost-effectiveness, and safety.

BMC INFECTIOUS DISEASES (2022)

添加到收藏夹

Article Geriatrics & Gerontology

Pharmacist-driven antimicrobial stewardship program in a long-term care facility by assessment of appropriateness

Maria Rosa Cantudo-Cuenca et al.

Summary: A pharmacist-led antibiotic stewardship program (ASP) in a long-term care facility (LTCF) has been effective in reducing the consumption of antibiotics and improving the appropriateness of treatment decisions. However, interventions in the emergency department are necessary due to the high rate of inappropriate antibiotic use in that setting.

EUROPEAN GERIATRIC MEDICINE (2022)

添加到收藏夹

Review Infectious Diseases

Comparison of the global prevalence and trend of human intestinal carriage of ESBL-producing Escherichia coli between healthcare and community settings: a systematic review and meta-analysis

Yihienew M. Bezabih et al.

Summary: The prevalence of ESBL E. coli in the intestinal tract of both patients and healthy individuals is increasing globally and regionally in both community and healthcare settings. The carriage rates in healthcare settings are generally higher than in community settings.

JAC-ANTIMICROBIAL RESISTANCE (2022)

添加到收藏夹

Article Immunology

Efficacy of Ceftazidime-avibactam Plus Aztreonam in Patients With Bloodstream Infections Caused by Metallo-β-lactamase-Producing Enterobacterales

Marco Falcone et al.

Summary: This study aimed to compare the outcomes of patients with MBL-producing Enterobacterales bloodstream infections treated with CAZ-AVI + ATM or other active antibiotics. The results showed that CAZ-AVI + ATM was associated with lower 30-day mortality, lower clinical failure at day 14, and shorter length of stay.

CLINICAL INFECTIOUS DISEASES (2021)

添加到收藏夹

Article Infectious Diseases

The antibiogram: key considerations for its development and utilization

William R. Truong et al.

Summary: The antibiogram is crucial for tracking antimicrobial resistance and guiding therapy, but institutions have not fully adopted standardized methods, emphasizing the importance of following CLSI guidelines to ensure accuracy and reliability. Understanding data limitations is key to appropriate clinical decision-making, along with accessible education on antibiogram use and consideration of an abbreviated version for frontline users.

JAC-ANTIMICROBIAL RESISTANCE (2021)

添加到收藏夹

Article Infectious Diseases

CON: Testing for ESBL production is unnecessary for ceftriaxone-resistant Enterobacterales

Amy J. Mathers et al.

Summary: Phenotypic testing for Enterobacterales with ESBLs is not additive to accurate beta-lactam MICs for clinical decision-making. ESBL testing is outdated and problematic due to inaccuracies when multiple classes of beta-lactamases are produced by the same organism. Clinical laboratories should focus on accurate susceptibility testing using contemporary interpretative criteria to guide therapeutic decisions.

JAC-ANTIMICROBIAL RESISTANCE (2021)

添加到收藏夹

Article Infectious Diseases

PRO: Testing for ESBL production is necessary for ceftriaxone-non-susceptible Enterobacterales: perfect should not be the enemy of progress

Pranita D. Tamma et al.

Summary: Relying solely on antibiotic susceptibility results to predict ESBL production in clinical isolates is inaccurate and may lead to carbapenem overuse. Accurate molecular assays detecting a range of ESBL genes are necessary to optimize patient care and address the potential silent epidemic of ESBL transmission.

JAC-ANTIMICROBIAL RESISTANCE (2021)

添加到收藏夹

Article Immunology

Infectious Diseases Society of America Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P. aeruginosa)

Pranita D. Tamma et al.

Summary: This guidance document provides recommendations for the treatment of antimicrobial-resistant infections caused by ESBL-E, CRE, and DTR-P. aeruginosa, with a focus on the United States. It discusses empiric treatment selection, duration of therapy, and other management considerations for both adults and children. The current version of the guidance is valid as of September 17, 2020, and will be updated periodically.

CLINICAL INFECTIOUS DISEASES (2021)

添加到收藏夹

Article Infectious Diseases

Characterization of Carbapenem-Resistant Enterobacteriaceae Clinical Isolates in Al Thawra University Hospital, Sana'a, Yemen

Sameer Ahmed Alsharapy et al.

MICROBIAL DRUG RESISTANCE (2020)

添加到收藏夹

Article Microbiology

Potency of Vaborbactam Is Less Affected than That of Avibactam in Strains Producing KPC-2 Mutations That Confer Resistance to Ceftazidime-Avibactam

Ruslan Tsivkovski et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)

添加到收藏夹

Article Infectious Diseases

Molecular and clinical epidemiology of carbapenem-resistant Enterobacterales in the USA (CRACKLE-2): a prospective cohort study

David van Duin et al.

LANCET INFECTIOUS DISEASES (2020)

添加到收藏夹

Article Infectious Diseases

Comparative in vitro activity of plazomicin and older aminoglyosides against Enterobacterales isolates; prevalence of aminoglycoside modifying enzymes and 16S rRNA methyltransferases

Deniz Gur et al.

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2020)

添加到收藏夹

Article Microbiology

Antibiotic Susceptibility of NDM-Producing Enterobacterales Collected in the United States in 2017 and 2018

Joseph D. Lutgring et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)

添加到收藏夹

Article Infectious Diseases

Expansion of acquired 16S rRNA methytransferases along with CTX-M-15, NDM and OXA-48 within three sequence types ofEscherichia colifrom northeast India

Jayalaxmi Wangkheimayum et al.

BMC INFECTIOUS DISEASES (2020)

添加到收藏夹

Article Immunology

Switching From Ceftriaxone to Cefotaxime Significantly Contributes to Reducing the Burden of Clostridioides difficile infections

Sebastian Wendt et al.

OPEN FORUM INFECTIOUS DISEASES (2020)

添加到收藏夹

Article Microbiology

In Vitro Activity of Cefiderocol, a Siderophore Cephalosporin, against Multidrug-Resistant Gram-Negative Bacteria

Shazad Mushtaq et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)

添加到收藏夹

Review Infectious Diseases

Overcoming Intrinsic and Acquired Resistance Mechanisms Associated with the Cell Wall of Gram-Negative Bacteria

Rachael E. Impey et al.

ANTIBIOTICS-BASEL (2020)

添加到收藏夹

Review Immunology

A Primer on AmpC β-Lactamases: Necessary Knowledge for an Increasingly Multidrug-resistant World

Pranita D. Tamma et al.

CLINICAL INFECTIOUS DISEASES (2019)

添加到收藏夹

Article Medicine, General & Internal

Once-Daily Plazomicin for Complicated Urinary Tract Infections

Florian M. E. Wagenlehner et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

添加到收藏夹

Article Microbiology

Distinct Roles of Outer Membrane Porins in Antibiotic Resistance and Membrane Integrity in Escherichia coli

Umji Choi et al.

FRONTIERS IN MICROBIOLOGY (2019)

添加到收藏夹

Review Infectious Diseases

Molecular mechanisms related to colistin resistance in Enterobacteriaceae

Zahra Aghapour et al.

INFECTION AND DRUG RESISTANCE (2019)

添加到收藏夹

Article Microbiology

Treatment of Multidrug-Resistant Vancomycin-Resistant Enterococcus faecium Hardware-Associated Vertebral Osteomyelitis with Oritavancin plus Ampicillin

Samira Dahesh et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)

添加到收藏夹

Review Microbiology

Epidemiology and Treatment of Multidrug-Resistant and Extensively Drug-Resistant Pseudomonas aeruginosa Infections

Juan P. Horcajada et al.

CLINICAL MICROBIOLOGY REVIEWS (2019)

添加到收藏夹

Article Infectious Diseases

CP-CRE/non-CP-CRE Stratification And CRE Resistance Mechanism Determination Help In Better Managing CRE Bacteremia Using Ceftazidime-Avibactam And Aztreonam-Avibactam

Hua Zou et al.

INFECTION AND DRUG RESISTANCE (2019)

添加到收藏夹

Review Biotechnology & Applied Microbiology

Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and alternative therapeutic strategies

Zheng Pang et al.

BIOTECHNOLOGY ADVANCES (2019)

添加到收藏夹

Article Infectious Diseases

Diversity of resistance mechanisms in carbapenem-resistant Enterobacteriaceae at a health care system in Northern California, from 2013 to 2016

Fiona Senchyna et al.

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2019)

添加到收藏夹

Article Infectious Diseases

In vitro activity of cefiderocol, a siderophore cephalosporin, against a recent collection of clinically relevant carbapenem-non-susceptible Gram-negative bacilli, including serine carbapenemase- and metallo-β-lactamase-producing isolates (SIDERO-WT-2014 Study)

Krystyna M. Kazmierczak et al.

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2019)

添加到收藏夹

Article Pharmacology & Pharmacy

Duration of Exposure to Antipseudomonal β-Lactam Antibiotics in the Critically Ill and Development of New Resistance

Besu F. Teshome et al.

PHARMACOTHERAPY (2019)

添加到收藏夹

Article Genetics & Heredity

Genetic Diversity of norA, Coding for a Main Efflux Pump of Staphylococcus aureus

Sofia Santos Costa et al.

FRONTIERS IN GENETICS (2019)

添加到收藏夹

Article Chemistry, Medicinal

Acinetobacter baumannii OmpA Is a Selective Antibiotic Permeant Porin

Ramkumar Iyer et al.

ACS INFECTIOUS DISEASES (2018)

添加到收藏夹

Review Infectious Diseases

Mechanisms of antimicrobial resistance among hospital-associated pathogens

Ayesha Khan et al.

EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2018)

添加到收藏夹

Review Infectious Diseases

Association of daptomycin dosing regimen and mortality in patients with VRE bacteraemia: a review

Farnaz Foolad et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2018)

添加到收藏夹

Article Medicine, General & Internal

Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With E coli or Klebsiella pneumoniae Bloodstream Infection and Ceftriaxone Resistance A Randomized Clinical Trial

Patrick N. A. Harris et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)

添加到收藏夹

Article Medicine, Research & Experimental

Genomic insights into nitrofurantoin resistance mechanisms and epidemiology in clinical Enterobacteriaceae

John Osei Sekyere

FUTURE SCIENCE OA (2018)

添加到收藏夹

Article Infectious Diseases

Effect and Safety of Meropenem-Vaborbactam versus Best-Available Therapy in Patients with Carbapenem-Resistant Enterobacteriaceae Infections: The TANGO II Randomized Clinical Trial

Richard G. Wunderink et al.

INFECTIOUS DISEASES AND THERAPY (2018)

添加到收藏夹

Review Microbiology

An overview of the antimicrobial resistance mechanisms of bacteria

Wanda C. Reygaert

AIMS MICROBIOLOGY (2018)

添加到收藏夹

Article Immunology

Phenotypic and Genotypic Characterization of Enterobacteriaceae Producing Oxacillinase-48-Like Carbapenemases, United States

Joseph D. Lutgring et al.

EMERGING INFECTIOUS DISEASES (2018)

添加到收藏夹

Article Microbiology

A Prolonged Outbreak of KPC-3-Producing Enterobacter cloacae and Klebsiella pneumoniae Driven by Multiple Mechanisms of Resistance Transmission at a Large Academic Burn Center

Hajime Kanamori et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)

添加到收藏夹

Article Microbiology

Emergence of Ceftazidime-Avibactam Resistance Due to Plasmid-Borne blaKPC-3 Mutations during Treatment of Carbapenem-Resistant Klebsiella pneumoniae Infections

Ryan K. Shields et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)

添加到收藏夹

Review Infectious Diseases

Role of cephalosporins in the era of Clostridium difficile infection

Mark H. Wilcox et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2017)

添加到收藏夹

Review Immunology

Clinical and laboratory considerations for the rapid detection of carbapenem-resistant Enterobacteriaceae

Ritu Banerjee et al.

VIRULENCE (2017)

添加到收藏夹

Review Infectious Diseases

PulseNet International: Vision for the implementation of whole genome sequencing (WGS) for global food-borne disease surveillance

Celine Nadon et al.

EUROSURVEILLANCE (2017)

添加到收藏夹

Article Infectious Diseases

Time to review the gold standard for genotyping vancomycin-resistant enterococci in epidemiology: Comparing whole-genome sequencing with PFGE and MLSTin three suspected outbreaks in Sweden during 2013-2015

Birgitta Lytsy et al.

INFECTION GENETICS AND EVOLUTION (2017)

添加到收藏夹

Article Microbiology

Widespread Fosfomycin Resistance in Gram-Negative Bacteria Attributable to the Chromosomal fosA Gene

Ryota Ito et al.

MBIO (2017)

添加到收藏夹

Article Immunology

Duodenoscope-Related Outbreak of a Carbapenem-Resistant Klebsiella pneumoniae Identified Using Advanced Molecular Diagnostics

Romney M. Humphries et al.

CLINICAL INFECTIOUS DISEASES (2017)

添加到收藏夹

Review Infectious Diseases

Anticipating the Unpredictable: A Review of Antimicrobial Stewardship and Acinetobacter Infections

Eric Wenzler et al.

INFECTIOUS DISEASES AND THERAPY (2017)

添加到收藏夹

Article Medical Laboratory Technology

Carbapenem-Resistant Enterobacteriaceae

Alina Lovleva et al.

CLINICS IN LABORATORY MEDICINE (2017)

添加到收藏夹

Review Microbiology

Antibiotic resistance in Staphylococcus aureus. Current status and future prospects

Timothy J. Foster

FEMS MICROBIOLOGY REVIEWS (2017)

添加到收藏夹

Article Microbiology

Multiyear, Multinational Survey of the Incidence and Global Distribution of Metallo-β-Lactamase-Producing Enterobacteriaceae and Pseudomonas aeruginosa

Krystyna M. Kazmierczak et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)

添加到收藏夹

Editorial Material Immunology

High Rates of Nonsusceptibility to Ceftazidime-avibactam and Identification of New Delhi Metallo-β-lactamase Production in Enterobacteriaceae Bloodstream Infections at a Major Cancer Center

Samuel L. Aitken et al.

CLINICAL INFECTIOUS DISEASES (2016)

添加到收藏夹

Article Immunology

Implementing an Antibiotic Stewardship Program: Guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America

Tamar F. Barlam et al.

CLINICAL INFECTIOUS DISEASES (2016)

添加到收藏夹

Article Infectious Diseases

Daptomycin versus linezolid for the treatment of vancomycin-resistant enterococcal bacteraemia: implications of daptomycin dose

Y-C. Chuang et al.

CLINICAL MICROBIOLOGY AND INFECTION (2016)

添加到收藏夹

Article Infectious Diseases

Comparison of 2 chromogenic media for the detection of extended-spectrum β-lactamase producing Enterobacteriaceae stool carriage in nursing home residents

Beth Blane et al.

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2016)

添加到收藏夹

Article Microbiology

In Vitro Activities of Ceftazidime-Avibactam, Aztreonam-Avibactam, and a Panel of Older and Contemporary Antimicrobial Agents against Carbapenemase-Producing Gram-Negative Bacilli

Shawn Vasoo et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)

添加到收藏夹

Article Computer Science, Artificial Intelligence

Interpretative reading of the antibiogram - a semi-naive Bayesian approach

Steen Andreassen et al.

ARTIFICIAL INTELLIGENCE IN MEDICINE (2015)

添加到收藏夹

Review Microbiology

Antibiotic resistance in the opportunistic pathogen Stenotrophomonas maltophilia

Maria B. Sanchez

FRONTIERS IN MICROBIOLOGY (2015)

添加到收藏夹

Review Microbiology

Enterobacter aerogenes and Enterobacter cloacae; versatile bacterial pathogens confronting antibiotic treatment

Anne Davin-Regli et al.

FRONTIERS IN MICROBIOLOGY (2015)

添加到收藏夹

Article Immunology

Prolonged use of oritavancin for vancomycin-resistantEnterococcus faeciumprosthetic valve endocarditis

Jennifer A. Johnson et al.

Open Forum Infectious Diseases (2015)

添加到收藏夹

Review Infectious Diseases

Mechanisms of antibiotic resistance in enterococci

William R. Miller et al.

EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2014)

添加到收藏夹

Article Microbiology

Enterobacteriaceae isolates carrying the New Delhi metallo-β-lactamase gene in Yemen

Alima Gharout-Sait et al.

JOURNAL OF MEDICAL MICROBIOLOGY (2014)

添加到收藏夹

Article Microbiology

The Target of Daptomycin Is Absent from Escherichia coli and Other Gram-Negative Pathogens

Christopher P. Randall et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)

添加到收藏夹

Review Microbiology

Intrinsic antibiotic resistance: Mechanisms, origins, challenges and solutions

Georgina Cox et al.

INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY (2013)

添加到收藏夹

Article Immunology

Linezolid in Methicillin-Resistant Staphylococcus aureus Nosocomial Pneumonia: A Randomized, Controlled Study

Richard G. Wunderink et al.

CLINICAL INFECTIOUS DISEASES (2012)

添加到收藏夹

Article Infectious Diseases

Evaluation of a diagnostic flow chart for detection and confirmation of extended spectrum β-lactamases (ESBL) in Enterobacteriaceae

S. Polsfuss et al.

CLINICAL MICROBIOLOGY AND INFECTION (2012)

添加到收藏夹

Review Infectious Diseases

OXA-48-like carbapenemases: the phantom menace

Laurent Poirel et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)

添加到收藏夹

Article Immunology

Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus Aureus Infections in Adults and Children: Executive Summary

Catherine Liu et al.

CLINICAL INFECTIOUS DISEASES (2011)

添加到收藏夹

Review Microbiology

Expert Systems in Clinical Microbiology

Trevor Winstanley et al.

CLINICAL MICROBIOLOGY REVIEWS (2011)

添加到收藏夹

Review Biochemistry & Molecular Biology

Genetic Basis of Antibiotic Resistance in Pathogenic Acinetobacter Species

Laurent Poirel et al.

IUBMB LIFE (2011)

添加到收藏夹

Article Microbiology

Detection of AmpC Beta-Lactamase in Escherichia coli: Comparison of Three Phenotypic Confirmation Assays and Genetic Analysis

S. Peter-Getzlaff et al.

JOURNAL OF CLINICAL MICROBIOLOGY (2011)

添加到收藏夹

Review Microbiology

Alarming beta-lactamase-mediated resistance in multidrug-resistant Enterobacteriaceae

Karen Bush

CURRENT OPINION IN MICROBIOLOGY (2010)

添加到收藏夹

Article Infectious Diseases

Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study

Karthikeyan K. Kumarasamy et al.

LANCET INFECTIOUS DISEASES (2010)

添加到收藏夹

Article Microbiology

Characterization of a New Metallo-beta-Lactamase Gene, bla(NDM-1), and a Novel Erythromycin Esterase Gene Carried on a Unique Genetic Structure in Klebsiella pneumoniae Sequence Type 14 from India

Dongeun Yong et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)

添加到收藏夹

Review Infectious Diseases

Stenotrophomonas maltophilia: an emerging opportunist human pathogen

W. John Looney et al.

LANCET INFECTIOUS DISEASES (2009)

添加到收藏夹

Article Infectious Diseases

Phenotypic detection of extended-spectrum beta-lactamase production in Enterobacteriaceae: review and bench guide

L. Drieux et al.

CLINICAL MICROBIOLOGY AND INFECTION (2008)

添加到收藏夹

Article Infectious Diseases

Molecular characterization of AmpC-producing Escherichia coli clinical isolates recovered in a French hospital

Hedi Mammeri et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)

添加到收藏夹

Article Chemistry, Medicinal

Physicochemical properties of antibacterial compounds: Implications for drug discovery

Rosemarie O'Shea et al.

JOURNAL OF MEDICINAL CHEMISTRY (2008)

添加到收藏夹

Article Chemistry, Medicinal

A minimalistic approach to identify substrate binding features in B1 Metallo-β-lactamases

Andres A. Poeylaut-Palena et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)

添加到收藏夹

Article Microbiology

First detection of the ambler class C 1 AmpC β-lactamase in Citrobacter freundii by a new, simple double-disk synergy test

Etienne Ruppe et al.

JOURNAL OF CLINICAL MICROBIOLOGY (2006)

添加到收藏夹

Article Medicine, General & Internal

Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus

Vance G. Fowler et al.

NEW ENGLAND JOURNAL OF MEDICINE (2006)

添加到收藏夹

Article Microbiology

Characterization of the naturally occurring oxacillinase of Acinetobacter baumannii

C Héritier et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)

添加到收藏夹

Review Infectious Diseases

Efflux-mediated antimicrobial resistance

K Poole

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)

添加到收藏夹

Article Microbiology

Practical methods using boronic acid compounds for identification of class C β-lactamase-producing Klebsiella pneumoniae and Escherichia coli

T Yagi et al.

JOURNAL OF CLINICAL MICROBIOLOGY (2005)

添加到收藏夹

Review Microbiology

Mechanisms of, and barriers to, horizontal gene transfer between bacteria

CM Thomas et al.

NATURE REVIEWS MICROBIOLOGY (2005)

添加到收藏夹

Article Oncology

Natural antibiotic susceptibility of Proteus spp.,, with special reference to P-mirabilis and P-penneri strains

I Stock

JOURNAL OF CHEMOTHERAPY (2003)

添加到收藏夹

Article Infectious Diseases

Occurrence and detection of AmpC β-lactamases among Gram-negative clinical isolates using a modified three-dimensional test at Guru Tegh Bahadur Hospital, Delhi, India

V Manchanda et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2003)

添加到收藏夹

Article Infectious Diseases

Clonal diversity and metallo-β-lactamase production in clinical isolates of Stenotrophomonas maltophilia

PS Mercuri et al.

MICROBIAL DRUG RESISTANCE (2002)

添加到收藏夹

Article Biotechnology & Applied Microbiology

Cellular impermeability and uptake of biocides and antibiotics in Gram-positive bacteria and mycobacteria

PA Lambert

JOURNAL OF APPLIED MICROBIOLOGY (2002)

添加到收藏夹

Article Infectious Diseases

Interpretative reading: recognizing the unusual and inferring resistance mechanisms from resistance phenotypes

DM Livermore et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2001)

添加到收藏夹

Article Infectious Diseases

Of Pseudomonas, porins, pumps and carbapenems

DM Livermore

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2001)

添加到收藏夹

Article Microbiology

Substrate specificities of MexAB-OprM, MexCD-OprJ, and MexXY-OprM efflux pumps in Pseudomonas aeruginosa

N Masuda et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)

添加到收藏夹

Review Pharmacology & Pharmacy

Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and impact on treatment

REW Hancock et al.

DRUG RESISTANCE UPDATES (2000)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.